GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Clinuvel Pharmaceuticals Limited American Depositary Shares CUVL · USD

US listing · 🇺🇸 United States

Compare

5.18

+1.57%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$67.7m

FY2022FY2026

Net income

$24.4m

FY2022FY2026

Free cash flow

—

FY2022FY2026

Shareholders' equity

$196.5m

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue$67.7m$68.4m$63.5m$56.4m$47.3m
Gross profit$56.3m$57.0m$56.2m$50.1m$39.8m
Research and development$13.0m————
Operating income$28.5m$32.9m$34.6m$31.8m$25.4m
Net income$24.4m$26.1m$25.7m$22.0m$15.0m
Diluted earnings per share0.480.520.510.450.30

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets$212.5m$195.7m$166.5m$139.5m$103.7m
Total liabilities$16.0m$22.3m$20.2m$20.9m$13.2m
Shareholders' equity$196.5m$173.4m$146.2m$118.6m$90.4m
Shares outstanding50m50m50m49m49m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Capital spending−$1.2m−$215,042−$4.0m−$740,076−$312,902
Dividends paid−$1.8m−$1.8m−$1.8m−$1.4m−$889,695

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.8%——
Operating income-3.6%——
Net income3.5%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin83.2%85.8%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings10.116.315.024.848.4
Price to sales3.66.56.410.115.9

Share price return

Finished calendar years

202520242023202220212020
Return9%-30%-25%-27%14%-13%

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 8 Sept 2026.

FY2027
Paid in the year0.036

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.